Quick answer
What is the molecular structure of NAD+, and what does it do in the lab? NAD+ (C21H27N7O14P2, about 663 g/mol) is a dinucleotide, not a peptide: an adenosine monophosphate unit and a nicotinamide mononucleotide unit joined through a pyrophosphate bridge. Its nicotinamide ring accepts a hydride to become NADH, which makes NAD+ the working cofactor of dehydrogenase assays, and it is also the substrate consumed by sirtuins, PARPs and NADases such as CD38. Because it is a small nucleotide and not an amino-acid chain, identity and purity are checked with nucleotide methods (UV spectra, HPLC, LC-MS) rather than peptide sequencing. It is supplied for laboratory research use only.
NAD+ sits oddly in a catalog of research peptides. The NAD+ 1000 mg product page says so itself: it is a dinucleotide, built from two nucleotides, and not a chain of amino acids. That difference shapes every decision downstream, from how identity is confirmed to how the solution is handled. This guide stays at the molecular level. It walks through the structure, the redox chemistry, the enzyme families that use NAD+ up, and the analytical consequences, so that a lab can read a certificate or design an assay with the chemistry in mind. For the wider catalog context see the NAD+ research overview; this article is intentionally narrower. The material is for laboratory research use only.
The structure: two nucleotides and one pyrophosphate
NAD+ is assembled from two mononucleotides. One carries adenine (adenosine monophosphate); the other carries nicotinamide (nicotinamide mononucleotide). Their 5′-phosphate groups are joined into a pyrophosphate linkage, so the molecule has a central diphosphate flanked by two ribose rings. The product page lists the molecular formula as C21H27N7O14P2 and describes the supplied form as lyophilized powder. Summing atomic masses for that formula gives roughly 663 g/mol, in line with the figure on the page.
Three structural features account for most of what NAD+ does in a laboratory. The nicotinamide ring is the redox-active part. The adenine ring is the part that absorbs ultraviolet light near 260 nm and is recognized by many enzyme binding pockets. The pyrophosphate bridge carries two negative charges at neutral pH and is the bond that NAD-consuming enzymes cleave or rearrange. A phosphate on the 2′-position of the adenosine ribose converts the molecule into NADP+, a distinct cofactor used by different enzymes; the two should not be interchanged in an assay.
| Structural element | Chemical role | Practical consequence |
|---|---|---|
| Nicotinamide ring | Accepts a hydride at the 4-position to form NADH | Oxidized and reduced forms have different absorbance spectra, which is how many assays read out |
| Adenine ring | Absorbs near 260 nm; binding determinant for enzymes | UV absorbance at 260 nm is a quick check of nucleotide concentration, not of purity |
| Pyrophosphate bridge | Bond cleaved by NAD-consuming enzymes | Also the group that can hydrolyze slowly in solution under poor storage |
| Two ribose rings | Link base to phosphate | Contribute to the highly polar, water-soluble character |
| 2′-phosphate (NADP+ only) | Distinguishes NADP+ from NAD+ | Different enzyme specificity; a mislabeled cofactor gives silent assay failure |
A short history of the molecule
NAD+ is among the oldest characterized cofactors. A review titled for its new life as a centenarian (Berger, 2004) frames it as a molecule first recognized more than a century ago for its role in fermentation chemistry and later found to have signaling functions as well. For most of the twentieth century it was regarded as a metabolic cofactor, a carrier of reducing equivalents between dehydrogenases and the respiratory chain. That view widened when the Sir2 protein of yeast was shown to be an NAD-dependent histone deacetylase (Imai et al., 2000), and when the Sir2 family was shown to catalyze an NAD–nicotinamide exchange reaction that requires an acetylated substrate (Landry et al., 2000). From that point NAD+ was studied not only as a cofactor that is recycled but as a substrate that is consumed.
The modern literature on NAD+ metabolism, summarized in reviews by Belenky and colleagues (2007) and Covarrubias and colleagues (2021), regards it as a node connecting energy metabolism, chromatin regulation, DNA-damage responses and signaling. This article only summarizes the chemistry that underlies that literature.
Redox chemistry: the NAD+/NADH couple
In a dehydrogenase reaction the substrate donates two electrons and a proton, and NAD+ accepts them as a hydride at the nicotinamide ring, becoming NADH. The reaction is reversible, and the ratio of the two forms is a common way to describe the redox state of a sample. The oxidized and reduced forms are distinguishable by spectroscopy: NADH absorbs strongly near 340 nm, where NAD+ does not, and that difference underlies the classic spectrophotometric dehydrogenase assay. A magnetic-resonance method has also been described for measuring NAD+ and NADH in intact tissue (Zhu et al., 2015), which illustrates that the redox pair is read out by very different instruments depending on the question.
For a laboratory using the supplied NAD+ as a standard or cofactor, the key point is that the oxidized form is the product on the shelf, and that its reduction state is set by the assay, not by the vial. A solution that has drifted toward other nucleotide species will not behave as a fresh standard, a topic covered separately in the NAD+ purity testing guide.
The three enzyme families that consume NAD+
Beyond its cofactor role, NAD+ is a co-substrate for enzymes that cleave the bond between nicotinamide and ribose. Three families dominate the literature.
| Enzyme family | What it does with NAD+ | Typical research readout |
|---|---|---|
| Sirtuins (SIRT1–7) | Remove acyl groups from lysine side chains, releasing nicotinamide and an acetyl-ADP-ribose product | Deacetylation of a peptide substrate; nicotinamide release |
| PARPs | Transfer ADP-ribose units to proteins, using NAD+ as the donor | ADP-ribose incorporation after DNA-damage stimulus |
| NADases such as CD38 | Hydrolyze NAD+ to ADP-ribose or cyclic ADP-ribose and nicotinamide | Loss of NAD+ in tissue extracts; product formation |
CD38 is notable for a research reason: one study reported that CD38 expression and activity increase with age in mice and that the enzyme is required for the age-related NAD decline observed there (Camacho-Pereira et al., 2016). The sirtuin biochemistry is reviewed by Sauve and colleagues (2006). A separate article, NAD+ research applications, covers how these enzyme assays are used.
Why NAD+ is not handled like a peptide
A peptide is characterized by its amino-acid sequence, so identity is confirmed by mass of the whole chain and, ideally, by fragmentation. NAD+ has no sequence. Identity rests on its mass, its UV absorbance profile (a maximum near 260 nm), its retention behavior on a reverse-phase or ion-pairing HPLC method against a reference standard, and, where an enzyme is available, on enzymatic activity. A reverse-phase HPLC method for quantitative NAD+ measurement in cells and tissues has been described (Yoshino and Imai, 2013), and a targeted LC-MS method for NAD+ and its related metabolites has been reported to overcome the specificity limits of UV detection in complex samples (Trammell and Brenner, 2013). These are tissue-extract methods, but the chromatographic logic carries over to checking a standard.
Purity percentages deserve the same caution here as for peptides. The product page states ≥98% by HPLC; that figure describes the fraction of the UV-absorbing signal that elutes as NAD+, and does not report water content, counter-ions, or the presence of species such as nicotinamide or ADP-ribose unless the method separates them. How a certificate is organized is explained in how to read a COA, and the vial's lot can be looked up in the COA library where a certificate has been published.
Reading the product page against the chemistry
The product page states a single 1000 mg size, purity of ≥98% by HPLC, the formula C21H27N7O14P2, lyophilized powder, and the storage line "Refrigerate at 2–8 °C; −20 °C for long-term. Protect from heat, moisture and light." The container is a sealed clear glass research vial. The page also lists the intended research areas: cellular-energy metabolism, mitochondrial-function research, and sirtuin-pathway and DNA-repair studies.
The formula is worth checking independently. A lab can compute the monoisotopic mass of C21H27N7O14P2 and compare it with the mass observed by LC-MS, which is a stronger identity test than UV alone. The storage line makes chemical sense for a polar, phosphate-rich solid: moisture is the main enemy of a lyophilized nucleotide, and cold storage slows hydrolysis. Handling after reconstitution follows the general rules in how long reconstituted peptides last, with the caveats about solution stability discussed in the sibling article on NAD+ degradation chemistry.
Design implications for an assay
Several practical points follow from the structure.
- Know which species the assay needs. A dehydrogenase assay needs the oxidized form as the starting cofactor and reads NADH formation at 340 nm; a sirtuin assay needs NAD+ as a co-substrate at a concentration chosen against the enzyme's apparent affinity.
- Control for nicotinamide. Nicotinamide is a product of every NAD-consuming reaction and was proposed as a negative regulator of yeast Sir2 and human SIRT1 (Bitterman et al., 2002), so a standard that contains it, or a reaction that accumulates it, can bias a sirtuin readout.
- Choose the buffer deliberately. A stability study of nicotinamide cofactors found faster degradation of the reduced form in phosphate buffer than in an alternative buffer (Rover et al., 1998); the buffer is therefore part of the experimental design, not a neutral background.
- Do not substitute NADP+ or NMN. Different phosphorylation and different ring-substituent chemistry mean different enzyme specificity; see NAD+ vs NMN vs NR for how the precursors differ.
- Calculate molarity from the formula weight and record the lot. Concentration arithmetic follows the standard relation (mass ÷ molar mass ÷ volume); the reconstitution calculator performs the unit conversion.
Longer-form discussion of how NAD+ levels are measured in tissue, and why published values differ between methods, is in the overview and in the sibling guides on sourcing and what NAD+ is.
What the structure does not tell you
A structure explains a mechanism; it does not substitute for evidence. The roles described above are established as biochemistry. Statements about what raising or lowering NAD+ does to a whole organism belong to a separate evidence base, and that base mixes yeast, worm, rodent and cell-culture work with measurements in human tissue whose interpretation is still debated. This article makes no claim in that area. For published work on age-associated changes in measured NAD levels, and the limits of that work, see the companion article on NAD+ and aging biology and the overview.
Frequently asked questions
Is NAD+ a peptide?
No. It is a dinucleotide made of two nucleotides, one carrying adenine and one carrying nicotinamide, joined through a pyrophosphate bridge. It has no amino-acid sequence, so identity is confirmed by mass, UV absorbance and chromatography rather than sequencing.
What is the molecular formula and mass of NAD+?
The product page lists C21H27N7O14P2. The molar mass calculated from that formula is about 663 g/mol.
What is the difference between NAD+ and NADH?
NAD+ is the oxidized form. Accepting a hydride at the nicotinamide ring converts it to NADH, the reduced form. NADH absorbs near 340 nm and NAD+ does not, which is the basis of many spectrophotometric enzyme assays.
What is the difference between NAD+ and NADP+?
NADP+ carries an additional phosphate on the 2′-position of the adenosine ribose. Enzymes distinguish the two, so one cannot stand in for the other in an assay.
Which enzymes consume NAD+?
The three families most often studied are sirtuins, PARPs and NADases such as CD38. All cleave the bond between nicotinamide and ribose and release nicotinamide.
Why is nicotinamide a concern in sirtuin assays?
It is a product of the reaction and was proposed as a negative regulator of Sir2 and human SIRT1 (Bitterman et al., 2002). Accumulation during a long incubation can therefore lower the apparent activity.
How is NAD+ identity confirmed?
By comparing observed mass with the mass calculated from the formula, checking the UV spectrum, and matching HPLC retention against a reference standard. Quantitative HPLC and LC-MS methods for NAD+ and its metabolites have been published.
Does a 98% HPLC purity figure describe the whole vial?
No. It describes the share of the chromatographic signal that corresponds to NAD+. Water, counter-ions and species that the method does not resolve are not captured.
Where do I find the storage conditions?
On the product page: refrigerate at 2–8 °C, −20 °C for long-term, and protect from heat, moisture and light.
Where can I do the concentration arithmetic?
Concentration is mass divided by molar mass divided by volume. The reconstitution calculator on this site performs the conversion; record the inputs in the lab notebook.
Research-use statement
All material discussed here is supplied for laboratory research use only; not for human consumption, and not a drug, food or cosmetic.
Related reading: NAD+ Stability: Degradation Chemistry and QC Checks, Comparing NAD+ Suppliers: A Lab Sourcing Framework, NAD+ and Sirtuins: Reaction Chemistry and Assay Design.
References
- Berger F. The new life of a centenarian: signalling functions of NAD(P). Trends in Biochemical Sciences. 2004;29(3):111-118. doi:10.1016/j.tibs.2004.01.007
- Belenky P, Bogan KL, Brenner C. NAD+ metabolism in health and disease. Trends in Biochemical Sciences. 2007;32(1):12-19. doi:10.1016/j.tibs.2006.11.006
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2020;22(2):119-141. doi:10.1038/s41580-020-00313-x
- Imai Si, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403(6771):795-800. doi:10.1038/35001622
- Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, et al. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. U.S.A.. 2000;97(11):5807-5811. doi:10.1073/pnas.110148297
- Sauve AA, Wolberger C, Schramm VL, Boeke JD. The Biochemistry of Sirtuins. Annu. Rev. Biochem.. 2006;75(1):435-465. doi:10.1146/annurev.biochem.74.082803.133500
- Camacho-Pereira J, Tarragó MG, Chini CC, Nin V, Escande C, Warner GM, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;23(6):1127-1139. doi:10.1016/j.cmet.2016.05.006
- Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1. Journal of Biological Chemistry. 2002;277(47):45099-45107. doi:10.1074/jbc.M205670200
- Rover L, Fernandes JC, Neto GdO, Kubota LT, Katekawa E, Serrano SH. Study of NADH Stability Using Ultraviolet–Visible Spectrophotometric Analysis and Factorial Design. Analytical Biochemistry. 1998;260(1):50-55. doi:10.1006/abio.1998.2656
- Yoshino J, Imai Si. Accurate Measurement of Nicotinamide Adenine Dinucleotide (NAD+) with High-Performance Liquid Chromatography. Methods in Molecular Biology. 2013;:203-215. doi:10.1007/978-1-62703-637-5_14
- Trammell SA, Brenner C. TARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD + METABOLITES. Comput Struct Biotechnol J. 2013;4(5):e201301012. doi:10.5936/csbj.201301012
- Zhu XH, Lu M, Lee BY, Ugurbil K, Chen W. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc. Natl. Acad. Sci. U.S.A.. 2015;112(9):2876-2881. doi:10.1073/pnas.1417921112
